WLP Stock UPDATES Wellpoint Health Networks Inc (WLP) 122.20

New Post Public Reply Private Reply Replies (0) Message Board

Oct 30, 2014 at 3:48 AM

Wellpoint Health Networks Inc (WLP) 122.20 $WLP

American Lung Association and WellPoint Collaborate to Help Educate About Childhood Asthma
Business Wire - Wed Oct 29, 11:02PM CDT
WellPoint, Inc., (NYSE:WLP) one of the nation's largest health benefits companies, today announced it has worked with the American Lung Association to develop an informative learning series to help address childhood asthma.
WLP: 122.20 (+2.20)

Wellpoint (WLP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Wed Oct 29, 7:37PM CDT
The following Wellpoint (WLP) conference call took place on October 29, 2014, 08:30 AM ET. This is a transcript of that earnings call:
WLP: 122.20 (+2.20)

After Yesterday's Rally of 1.83% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 29, 3:49PM CDT
WellPoint (NYSE:WLP) traded in a range yesterday that spanned from a low of $121.09 to a high of $123.80. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $120.87 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WLP: 122.20 (+2.20)

Look for Shares of WellPoint to Potentially Pullback after Yesterday's 1.83% Rise
Comtex SmarTrend(R) - Wed Oct 29, 3:48PM CDT
WellPoint (NYSE:WLP) traded in a range yesterday that spanned from a low of $121.09 to a high of $123.80. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $120.87 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WLP: 122.20 (+2.20)

WellPoint Posts Strong Q3 Earnings on High Membership - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 2:00PM CDT
WellPoint Inc. (WLP) reported third-quarter 2014 adjusted income of $2.36 per share, beating the Zacks Consensus Estimate of $2.28.
UNH: 92.96 (+0.32), AET: 79.75 (+2.52), WLP: 122.20 (+2.20), HUM: 134.95 (+0.22)

WellPoint (WLP) Stock Higher Today After Increasing Forecast
at The Street - Wed Oct 29, 7:26AM CDT
The health insurer increased its forecasts for profit and membership of its medical plans as earnings beat estimates.
WLP: 122.20 (+2.20)

WellPoint Reports Third Quarter 2014 Results
Business Wire - Wed Oct 29, 5:00AM CDT
--Medical enrollment increased sequentially by 259,000 members, or 0.7 percent, totaling approximately 37.5 million members as of September 30, 2014.
WLP: 122.20 (+2.20)

Right Time to Invest in Health Insurance Stocks? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 2:34AM CDT
Right Time to Invest in Health Insurance Stocks? - Industry Outlook
CI: 94.00 (+1.42), HIIQ: 9.51 (-0.20), UNH: 92.96 (+0.32), AET: 79.75 (+2.52), WLP: 122.20 (+2.20), HUM: 134.95 (+0.22)

Video: Aetna Falls On Costs; Centene Up On Medicaid
at Investor's Business Daily - Tue Oct 28, 11:38AM CDT
Aetna (AET) beat forecasts and raised its earnings guidance for the year, but shares are down amid higher patient medical costs. The insurance provider's earnings rose 19.3% to $1.79 a share, handily topping views by 21 cents, and revenue grew 13.1%...
CNC: 89.85 (+1.20), GILD: 110.72 (-2.73), UNH: 92.96 (+0.32), AET: 79.75 (+2.52), WLP: 122.20 (+2.20)

Health Insurance: Obamacare Transforming the Industry - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:49AM CDT
Health Insurance: Obamacare Transforming the Industry - Industry Outlook
CI: 94.00 (+1.42), UNH: 92.96 (+0.32), HNT: 46.90 (+0.26), MOH: 46.50 (-0.60), WLP: 122.20 (+2.20), HUM: 134.95 (+0.22)

Health Insurance: Obamacare Transforming the Industry - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:49AM CDT
Health Insurance: Obamacare Transforming the Industry - Zacks Analyst Interviews
CI: 94.00 (+1.42), UNH: 92.96 (+0.32), HNT: 46.90 (+0.26), MOH: 46.50 (-0.60), WLP: 122.20 (+2.20), HUM: 134.95 (+0.22)

Will WellPoint (WLP) Surpass Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:00PM CDT
WellPoint Inc. (WLP) is set to report third-quarter 2014 earnings results on Oct 29, 2014.
MDVN: 99.55 (-1.63), AMSG: 51.58 (+0.20), CRL: 64.47 (+0.42), WLP: 122.20 (+2.20)

Position Paper Release, Acquisition Agreement, Quarterly Earnings, Technical Updates, and New Medicare Plans - Research Reports on Intercontinental, Marsh & McLennan, Waters, Teva and WellPoint
PR Newswire - Mon Oct 27, 7:50AM CDT
Today, Analysts Review released its research reports regarding Intercontinental Exchange, Inc. (NYSE: ICE), Marsh & McLennan Companies, Inc. (NYSE: MMC), Waters Corporation (NYSE: WAT), Teva Pharmaceutical Industries Limited (NYSE: TEVA) and WellPoint Inc. (NYSE: WLP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7440-100free.
ICE: 205.93 (+0.52), TEVA: 54.49 (-0.31), WLP: 122.20 (+2.20), WAT: 109.87 (-0.13), MMC: 52.88 (-0.07)

WellPoint Offers Five Tips For Keeping Eyes Safe When Wearing Decorative Contact Lenses This Halloween
Business Wire - Mon Oct 27, 3:00AM CDT
Halloween is just around the corner, and many people are shopping for unique outfits to wear on this special night. However, there's one item that some people wear that can be more dangerous than people think...decorative contact lenses. People of all ages are interested in wearing these lenses because they can add the perfect touch to a Halloween costume.
WLP: 122.20 (+2.20)

When It Comes to Obamacare, This Is What Matters Most to Consumers
Sean Williams, The Motley Fool - Motley Fool - Sun Oct 26, 9:11AM CDT
Source: White House on Flickr. In just three weeks open enrollment for the Affordable Care Act, or ACA (but better known as Obamacare), will kick off for its second year. Of course, things will be a lot different this time around. Insurers and...
CNC: 89.85 (+1.20), UNH: 92.96 (+0.32), WLP: 122.20 (+2.20), MOH: 46.50 (-0.60)

The Real Reason Many Americans Dislike Obamacare
Sean Williams, The Motley Fool - Motley Fool - Sat Oct 25, 9:11AM CDT
Source: White House on Flickr It's no secret that Obamacare, known officially as the Affordable Care Act, is a polarizing law that has drawn a pretty strict divide between supporters and those who oppose it. According to the Kaiser Family...
CNC: 89.85 (+1.20), WLP: 122.20 (+2.20)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Oct 24, 6:54PM CDT
Earnings will take center stage and Cramer will be watching Merck, Twitter and Facebook, among many others.
BDSI: 17.38 (+0.21), GPRO: 67.89 (-1.41), MCK: 198.45 (-2.75), AXP: 88.34 (+0.33), PNRA: 165.42 (-5.58), FB: 75.86 (-4.91), DECK: 85.24 (-0.01), XOM: 94.59 (-0.51), BWLD: 149.35 (-2.33), SO: 46.42 (-0.95), PANW: 103.56 (-1.85), PAA: 55.73 (-0.30), WLP: 122.20 (+2.20), SBUX: 76.54 (-0.51), PH: 123.97 (+1.02), GILD: 110.72 (-2.73), MRK: 56.20 (+0.35), DD: 66.80 (-1.15), PAY: 36.88 (+0.33), TWTR: 42.08 (-1.70), CVX: 117.14 (+0.01), AAPL: 107.34 (+0.60), HLSS: 18.03 (+0.01)

UnitedHealth Touches 52-Week High on Strong Q3 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 9:13AM CDT
UnitedHealth (UNH) scales 52 week high on the back of strong third quarter results.
CI: 94.00 (+1.42), UNH: 92.96 (+0.32), AET: 79.75 (+2.52), WLP: 122.20 (+2.20)

WellPoint Rises 1.08% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Oct 20, 4:31PM CDT
WellPoint (NYSE:WLP) traded in a range yesterday that spanned from a low of $115.00 to a high of $116.60. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $115.94 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WLP: 122.20 (+2.20)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...